RxDoctor Payments Data

Kavita Grover, MD

Neurology · Detroit, MINPI 1790808947

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,160 of the $34,814 with a category attached, or 80.9%. It is spread thinly across 11 manufacturers, the largest accounting for just 19.6%. Among neurology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,814in general payments, 2019–2025

Across 55 payments — averaging $632.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Scientific Affairs, LLC$7K
  • Amgen$6K
  • Argenx US, Inc.$6K
  • Johnson & Johnson$5K
  • Janssen Global Services, LLC$3K
  • AstraZeneca$3K
  • plus $4K from 5 others
$201,428in research payments, 2019–2025

Across 43 payments — averaging $4684.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB SA$55K
  • Catalyst Pharmaceuticals, Inc.$51K
  • Argenx US, Inc.$51K
  • Takeda Pharmaceuticals U.S.A., Inc.$35K
  • AstraZeneca$9K
  • Novartis$1K

What the payments were for

  • Consulting fees$28,16081%
  • Speaking & faculty fees$3,2709%
  • Travel & lodging$1,7695%
  • Food & beverage$1,5975%
  • Education$190%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,814 in reported general payments places this provider in the 90th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$37,286
Medicare patients
150
Services billed
856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5012$188,582
Mycophenolate Mofetil154$30,892
Pyridostigmine Bromide212$21,388
Azathioprine77$7,074
Pyridostigmine Bromide ErPyridostigmine Bromide18$5,809
Prednisone340$2,623
Gabapentin64$932
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$873
Duloxetine Hcl23$536
Pregabalin35$293
Omeprazole19$110

Paid to pharmacies, not to this prescriber.

Other neurology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →